Product ID:4943 MAGNESIUM SULFATE INJECTION USP
MSDS Date:06/21/1996
FSC:NIIN:Submitter:F BT
Status Code:A
MSDS Number: CJLQX

Emergency Phone: 847-937-7970

Info Phone: 708-937-6100

Cage: 60060

Telephone: 847-935-7177

Cage: 60060

MAGNESIUM SULFATE HEPTAHYDRATE

CAS: 10034-99-8

RTECS: OM4508000

DEXTROSE

CAS: 50-99-7

RTECS: LZ6600000

Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Health Hazards Acute and Chronic:THIS MATERIAL IS USED AS AN
ANTICONVULSANT. INGESTION: CAN RESULT IN A LAXATIVE EFFECT. MAY
AFFECT THE GASTROINTESTINAL TRACT, NERVOUS SYSTEM, CARDIOVASCULAR
SYSTEM & HEART. ADMINISTRATION TO PREGNANT WOMEN PRIOR TO DELIVERY
CAN RESULT IN HYPOTENSION, HYPOREFLEXIA, HYPOTENIA & RESPIRATORY
DEPRESSION IN THE NEONATE.
Effects of Overexposure:NAUSEA, VOMITING, ABDOMINAL PAIN, DIARRHEA,
ELECTROLYTE LOSS, SEDATION, FLUSHING, SWEATING, HYPOTENSION,
HYPOTHERMIA, REDUCED RESPIRATION RATE, HYPOTONIA, DEPRESSED
REFLEXES, REDUCED HEART RATE, ALTER ED ECG & CIRCULATORY COLLAPSE.
Medical Cond Aggravated by Exposure:HEART BLOCK, MYOCARDIAL DAMAGE,
MAGNESIUM INTOXICATION, AILMENTS OF RESPIRATORY, RENAL & GI.
CONCURRENT USE OF NERVOUS SYSTEM DEPRESSANT, NEUROMUSCULAR BLOCKING
DRUGS & CARDIAC GLYCOSIDE.

First Aid:EYES/SKIN: REMOVE FROM SOURCE OF EXPOSURE. FLUSH W/COPIOUS
AMOUNTS OF WATER. INGESTION: INDUCE EMESIS/PERFORM GASTRIC LAVAGE
IF PATIENT IS ALERT. INTRAVENOUS CALCIUM GLUCONATE CAN COUNTERACT
THE EFFEC TS OF HYPERMAGNESEMIA. PROVIDE SYMPTOMATIC/SUPPORTIVE
CARE, MONITOR CARDIOVASCULAR & RESPIRATORY.

Extinguishing Media:USE MEDIA APPROPRIATE FOR PRIMARY CAUSE OF FIRE.
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS, FLAME
& CHEMICAL RESISTANT CLOTHING, BOOTS & GLOVES.

Spill Release Procedures:ABSORB W/SUITABLE MATERIAL & PLACE INTO
CONTAINER FOR DISPOSAL.

Handling and Storage Precautions:STORE AT ROOM TEMPERATURE 77F. AVOID
EXCESSIVE HEAT. PROTECT FROM FREEZING.

Respiratory Protection:NOT NEEDED DURING NORMAL PRODUCT USE.
Ventilation:NO SPECIAL PROVISIONS REQUIRED UNDER NORMAL PRODUCT USE.
Protective Gloves:IMPERVIOUS
Eye Protection:RECOMMENDED ONLY IF CONTACT IS LIKELY.
Supplemental Safety and Health

pH:3.5-7
Solubility in Water:WATER SOLUBLE
Appearance and Odor:CLEAR ODORLESS SOLUTION

Stability Condition to Avoid:EXCESSIVE HEAT, FREEZING
Hazardous Decomposition Products:BY HEATING: TOXIC FUMES OF SULFUR
OXIDES

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/LOCAL, STATE &
FEDERAL REGULATIONS.

Toxicological Information:IN CLINICAL USE, MAGNESIUM SULFATE IS USED
ORALLY AS A LAXATIVE & IS GIVEN BY INJECTION TO TREAT CONVULSIONS &
MAGNESIUM DEFICIENCY. IT ACTS TO DEPRESS THE NERVOUS SYSTEM &
ALTERS CARDIAC & CARDIOVASC ULAR FUNCTION.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Transport Information:NOT REGULATED.